Superior long-term outcomes of allogeneic hematopoietic cell transplantation when transplanted in response compared to relapsed or refractory after hypomethylating agents for patients with lower risk myelodysplastic syndrome

被引：0
|
作者：
Moon, J. H. [1 ]
Sohn, S. K. [1 ]
Ahn, J. S. [2 ]
Kim, H. J. [2 ]
Do, Y. -R. [3 ]
Song, M. K. [4 ]
Shin, H. J. [4 ]
Lee, W. S. [5 ]
Lee, S. M. [5 ]
Joo, Y. D. [6 ]
Kim, H. [7 ]
Lee, H. S. [8 ]
Kim, Y. S. [8 ]
Cho, Y. Y. [9 ]
Bae, S. H. [9 ]
机构：
[1] Kyungpook Natl Univ Hosp, Hematol Oncol, Deagu, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Hwasun, South Korea
[3] Keimyung Univ, Dongsan Med Ctr, Hematol Oncol, Deagu, South Korea
[4] Busan Natl Univ Hosp, Hematol Oncol, Busan, South Korea
[5] Inje Univ, Busan Baik Hosp, Hematol Oncol, Busan, South Korea
[6] Inje Univ, Haewoondae Baik Hosp, Hematol Oncol, Busan, South Korea
[7] Ulsan Univ Hosp, Hematol Oncol, Ulsan, South Korea
[8] Kosin Univ, Gosper Hosp, Hematol Oncol, Busan, South Korea
[9] Daegu Catholic Univ, Med Ctr, Hematol Oncol, Deagu, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P363
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [1] SUPERIOR LONG-TERM OUTCOMES OF LOWER RISK MDS PATIENTS WHEN TRANSPLANTED IN RESPONSE COMPARED TO RELAPSED OR REFRACTORY TO HMA
    Lee, Y. J.
    Moon, J. H.
    Sohn, S. K.
    Ahn, J. S.
    Kim, H. J.
    Song, M. K.
    Shin, H. J.
    Lee, W. S.
    Lee, S. M.
    Joo, Y. D.
    Kim, H.
    Kim, D. Y.
    Lee, H. S.
    Kim, Y. S.
    Cho, Y. Y.
    HAEMATOLOGICA, 2015, 100 : 70 - 70
  • [2] SUPERIOR LONG-TERM OUTCOMES OF ALLOGENEIC HCT IN RESPONSE COMPARED TO RELAPSED OR REFRACTORY AFTER HMA FOR PATIENTS WITH LOWER RISK MDS
    Moon, J. H.
    Sohn, S. K.
    Ahn, J. S.
    Kim, H. J.
    Do, Y. R.
    Song, M. K.
    Shin, H. J.
    Lee, W. S.
    Lee, S. M.
    Joo, Y. D.
    Kim, H.
    Lee, H. S.
    Kim, Y. S.
    Cho, Y. Y.
    Bae, S. H.
    LEUKEMIA RESEARCH, 2015, 39 : S41 - S42
  • [3] Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome
    Kim, D-Y
    Lee, J-H
    Park, Y-H
    Lee, J-H
    Kim, S-D
    Choi, Y.
    Lee, S-B
    Lee, K-H
    Ahn, S. Y.
    Lee, Y-S
    Seol, M.
    Kang, Y-A
    Jeon, M.
    Jung, A. R.
    Lee, Y-J
    Lee, K-H
    BONE MARROW TRANSPLANTATION, 2012, 47 (03) : 374 - 379
  • [4] FEASIBILITY OF HYPOMETHYLATING AGENTS FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Park, Y. H.
    Lee, J. H.
    Kim, D. Y.
    Lee, J. H.
    Lim, S. N.
    Kim, S. D.
    Choi, Y.
    Lee, S.
    Lee, K. H.
    Kim, J. Y.
    Lee, Y. S.
    Seol, M.
    Kang, Y. A.
    Jeon, M.
    Lee, Y. J.
    Lee, K. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 128 - 128
  • [5] Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome
    D-Y Kim
    J-H Lee
    Y-H Park
    J-H Lee
    S-D Kim
    Y Choi
    S-B Lee
    K-H Lee
    S Y Ahn
    Y-S Lee
    M Seol
    Y-A Kang
    M Jeon
    A R Jung
    Y-J Lee
    K-H Lee
    Bone Marrow Transplantation, 2012, 47 : 374 - 379
  • [6] Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
    Dong Won Baek
    Yoo Jin Lee
    Hyunjeong Kim
    Seo Yeon Ahn
    Jae Sook Ahn
    Ho Jin Shin
    Won Sik Lee
    Sang Min Lee
    Ik Chan Song
    Ho Sup Lee
    Sung Woo Park
    Yunsuk Choi
    Yoon Young Cho
    Sung Hwa Bae
    Hyeoung Joon Kim
    Sang Kyun Sohn
    Joon Ho Moon
    Annals of Hematology, 2018, 97 : 2309 - 2317
  • [7] Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
    Baek, Dong Won
    Lee, Yoo Jin
    Kim, Hyunjeong
    Ahn, Seo Yeon
    Ahn, Jae Sook
    Shin, Ho Jin
    Lee, Won Sik
    Lee, Sang Min
    Song, Ik Chan
    Lee, Ho Sup
    Park, Sung Woo
    Choi, Yunsuk
    Cho, Yoon Young
    Bae, Sung Hwa
    Kim, Hyeoung Joon
    Sohn, Sang Kyun
    Moon, Joon Ho
    ANNALS OF HEMATOLOGY, 2018, 97 (12) : 2309 - 2317
  • [8] Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome
    Park, Sungwoo
    Baek, Dong Won
    Sohn, Sang Kyun
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Shin, Ho Fin
    Chung, Joo Seop
    Lee, Sang Min
    Lee, Won Sik
    Lim, Sung Nam
    Lee, Yoo Fin
    Choi, Yunsuk
    Lee, Ho Sup
    Cho, Yoon Young
    Lee, Gyeong-Won
    Moon, Joon Ho
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07): : E367 - E373
  • [9] Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective casecontrol study
    Jabbour, Elias
    Mathisen, Michael S.
    Garcia-Manero, Guillermo
    Champlin, Richard
    Popat, Uday
    Khouri, Issa
    Giralt, Sergio
    Kadia, Tapan
    Chen, Julianne
    Pierce, Sherry
    Koca, Ebru
    Daver, Naval
    Tanaka, Maria
    Rondon, Gabriela
    Oran, Betul
    Parmar, Simrit
    Kantarjian, Hagop
    de Lima, Marcos
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) : 198 - 200
  • [10] FAVORABLE OUTCOMES WITH TUMOR BURDEN REDUCTION WITH HYPOMETHYLATING AGENTS BEFORE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLNATATION FOR PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME
    Park, S. W.
    Kim, J. Y.
    Lee, Y. J.
    Sohn, S. K.
    Ahn, J. S.
    Kim, H. J.
    Shin, H. J.
    Lee, W. S.
    Lee, S. M.
    Joo, Y. D.
    Kim, H.
    Lee, H. S.
    Kim, Y. S.
    Cho, Y. Y.
    Moon, J. H.
    HAEMATOLOGICA, 2016, 101 : 504 - 504
12345